Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,536 | 1,120 | 99.5% |
| Education | $83.86 | 15 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,222 | 182 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,758 | 113 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,526 | 97 | $0 (2024) |
| ABBVIE INC. | $1,171 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,126 | 76 | $0 (2024) |
| PFIZER INC. | $1,022 | 75 | $0 (2024) |
| Lilly USA, LLC | $910.57 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $483.45 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $475.20 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $453.53 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,278 | 136 | Boehringer Ingelheim Pharmaceuticals, Inc. ($320.19) |
| 2023 | $2,443 | 145 | AbbVie Inc. ($303.33) |
| 2022 | $2,171 | 142 | Novo Nordisk Inc ($370.78) |
| 2021 | $2,263 | 168 | Novo Nordisk Inc ($331.62) |
| 2020 | $1,798 | 139 | Novo Nordisk Inc ($322.84) |
| 2019 | $2,064 | 142 | Smith+Nephew, Inc. ($282.57) |
| 2018 | $1,768 | 127 | AstraZeneca Pharmaceuticals LP ($290.80) |
| 2017 | $1,835 | 136 | AstraZeneca Pharmaceuticals LP ($328.97) |
All Payment Transactions
1,135 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: DIABETES | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $19.37 | General |
| Category: GI | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: PAIN | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Hematology | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,868 | 5,252 | $562,722 | $266,627 |
| 2022 | 35 | 3,140 | 5,375 | $633,857 | $294,869 |
| 2021 | 33 | 2,749 | 4,753 | $533,819 | $254,884 |
| 2020 | 34 | 2,845 | 4,693 | $517,236 | $211,468 |
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 585 | 1,459 | $255,325 | $113,084 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 481 | 739 | $88,680 | $43,328 | 48.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 329 | 329 | $57,575 | $39,912 | 69.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 207 | 210 | $15,750 | $14,732 | 93.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 32 | $12,448 | $8,745 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 214 | 217 | $14,973 | $6,133 | 41.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 27 | $14,661 | $5,449 | 37.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 124 | 138 | $10,902 | $5,393 | 49.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 140 | 302 | $12,684 | $4,739 | 37.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 100 | $10,400 | $4,731 | 45.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $7,440 | $3,487 | 46.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 31 | 42 | $15,666 | $3,059 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $4,275 | $2,411 | 56.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 45 | 164 | $7,872 | $2,256 | 28.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 103 | 192 | $7,872 | $1,888 | 24.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 116 | 118 | $5,900 | $1,832 | 31.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,805 | $1,729 | 61.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 44 | 45 | $1,710 | $1,244 | 72.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 32 | 32 | $2,528 | $1,039 | 41.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 42 | 55 | $1,155 | $497.34 | 43.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 46 | $4,278 | $476.52 | 11.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 96 | 118 | $3,658 | $259.60 | 7.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 28 | 105 | $525.00 | $119.16 | 22.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 69 | 676 | $3,380 | $60.35 | 1.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 52 | $260.00 | $22.59 | 8.7% |
About Dr. Cory Smith, MD
Dr. Cory Smith, MD is a Family Medicine healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487767596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cory Smith, MD has received a total of $16,619 in payments from pharmaceutical and medical device companies, with $2,278 received in 2024. These payments were reported across 1,135 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($16,536).
As a Medicare-enrolled provider, Smith has provided services to 11,602 Medicare beneficiaries, totaling 20,073 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Florence, SC
- Active Since 08/16/2006
- Last Updated 02/18/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487767596
Products in Payments
- Ozempic (Drug) $1,105
- TRADJENTA (Drug) $1,037
- JARDIANCE (Drug) $648.37
- FARXIGA (Drug) $595.76
- TRELEGY ELLIPTA (Drug) $594.22
- UBRELVY (Drug) $473.80
- XARELTO (Drug) $436.39
- TRULICITY (Drug) $424.76
- ELIQUIS (Drug) $413.76
- VRAYLAR (Drug) $321.74
- Vascepa (Drug) $313.52
- Rybelsus (Drug) $309.28
- SYMBICORT (Drug) $294.19
- Journey II BCS (Device) $282.57
- Victoza (Drug) $277.38
- NURTEC ODT (Drug) $253.55
- EMGALITY (Drug) $251.68
- JANUVIA (Drug) $250.71
- ENTRESTO (Drug) $249.76
- XIFAXAN (Drug) $249.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Florence
Dr. Bradley Gray
Family Medicine — Payments: $23,764
Donald Behling, Md, MD
Family Medicine — Payments: $16,401
Clarence Alexander, Md, MD
Family Medicine — Payments: $15,630
Dr. Guy Mcclary, Md, MD
Family Medicine — Payments: $15,201
Dr. Edward Schumann, Md, MD
Family Medicine — Payments: $14,923
Dr. Ralph Crowe, M.d, M.D
Family Medicine — Payments: $14,896